Neoadjuvant Response-guided Treatment of Luminal B-type Tumors and Luminal A-type Tumors With Node Metastases

NCT02603679 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

181

Enrollment

OTHER

Sponsor class

Conditions

Early-Stage Breast Carcinoma
Estrogen Receptor Positive Tumor

Interventions

DRUG: Paclitaxel
DRUG: Tamoxifen + Palbociclib
DRUG: Aromatase Inhibitor + Palbociclib
DRUG: Goserelin + Aromatase Inhibitor + Palbociclib

Sponsor

Thomas Hatschek